Education
About Us
Working with TipRanks
Follow Us
Afya (AFYA)
NASDAQ:AFYA
AFYA Stock Chart & Stats
$15.04
$0.11(0.70%)
At close: 4:00 PM EST
$15.04
$0.11(0.70%)
Day’s Range― - ―
52-Week Range$13.12 - $19.90
Previous CloseN/A
Volume36.70K
Average Volume (3M)78.52K
Market Cap
$1.36B
Enterprise Value$9.12B
Total Cash (Recent Filing)$996.83M
Total Debt (Recent Filing)$2.97B
Price to Earnings (P/E)10.7
Beta0.70
Next Earnings
Mar 27, 2026EPS Estimate
0.35Next Dividend Ex-DateN/A
Dividend Yield<0.01%
Share Statistics
EPS (TTM)0.40
Shares Outstanding46,894,950
10 Day Avg. Volume78,346
30 Day Avg. Volume78,516
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)2.08
Price to Sales (P/S)2.68
P/FCF Ratio8.53
Enterprise Value/Market Cap6.69
Enterprise Value/Revenue2.51
Enterprise Value/Gross Profit3.86
Enterprise Value/Ebitda5.67
Forecast
1Y Price Target
$18.90Price Target Upside25.66% Upside
Rating ConsensusHold
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue OutlookAnalyst expects organic, broad-based net revenue growth across segments with modest margin expansion supporting profitability.
Student Financing ProgramsHigher usage of FIES and Prouni sustains pricing and occupancy ratios, improving operational leverage as enrollments stabilize.
Tuition AdjustmentManagement's targeted tuition readjustment of about 5% for 2026 should help preserve revenue per student and offset cost pressures.
Bears Say
Capacity Risk From Seat CutsReduction in projected seat additions for existing courses constrains revenue upside and could slow enrollment-driven cash generation.
Investment-driven Margin PressureIncreased investments in new initiatives and educational technologies are likely to pressure profit margins as the company prioritizes growth over near-term profitability.
Tax HeadwindsEffective tax rate converging toward the OECD minimum near 15% would reduce reported net income and free cash flow available to shareholders.
Afya News
AFYA FAQ
What was Afya’s price range in the past 12 months?
Afya lowest stock price was $13.12 and its highest was $19.90 in the past 12 months.
What is Afya’s market cap?
Afya’s market cap is $1.36B.
When is Afya’s upcoming earnings report date?
Afya’s upcoming earnings report date is Mar 27, 2026 which is in 53 days.
How were Afya’s earnings last quarter?
Afya released its earnings results on Nov 12, 2025. The company reported $0.4 earnings per share for the quarter, beating the consensus estimate of $0.328 by $0.072.
Is Afya overvalued?
According to Wall Street analysts Afya’s price is currently Undervalued.
Does Afya pay dividends?
Afya pays a Notavailable dividend of $0.232 which represents an annual dividend yield of <0.01%. See more information on Afya dividends here
What is Afya’s EPS estimate?
Afya’s EPS estimate is 0.35.
How many shares outstanding does Afya have?
Afya has 46,894,950 shares outstanding.
What happened to Afya’s price movement after its last earnings report?
Afya reported an EPS of $0.4 in its last earnings report, beating expectations of $0.328. Following the earnings report the stock price went up 1.384%.
Which hedge fund is a major shareholder of Afya?
Currently, no hedge funds are holding shares in AFYA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Afya Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$18.90 (25.66% Upside)
$18.90 (25.66% Upside)
Blogger Sentiment
Neutral
AFYA Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.20%
12-Months-Change
Fundamentals
Return on Equity
15.51%
Trailing 12-Months
Asset Growth
7.81%
Trailing 12-Months
Company Description
Afya
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
AFYA Company Deck
AFYA Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with significant growth in revenue, profitability, and strategic achievements. However, there were some challenges in user retention within specific segments. The company's strong financial performance and strategic initiatives outweighed the noted challenges.View all AFYA earnings summariesAFYA Stock 12 Month Forecast
Average Price Target
$18.90
▲(25.66% Upside)
Technical Analysis
Ownership Overview
17.40%
Insiders
9.95% Mutual Funds
12.03% Other Institutional Investors
60.15% Public Companies and
Individual Investors